Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention

NCT06916520 is registered in ClinicalTrials.gov with J.P.S Henriques as lead sponsor.

NCT NCT06916520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06916520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention
Lead sponsor
J.P.S Henriques
Phase
Phase 4
Overall status
Recruiting
Start date
November 13, 2025
Completion date
April 30, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), percutaneous coronary intervention (pci)